Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Fulvestrant Beta-Isomer | Fulvestrant Beta-Isomer, a drug utilized in the management of metastatic breast cancer associated with hormone receptor positivity, acts as a selective estrogen receptor down-regulator that impedes breast cancer cell growth by binding to and disintegrating estrogen receptors. Its modus operandi is to lower the expression of estrogen receptors. Group: Pharmaceutical. Alternative Names: (7β,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; Fulvestrant EP Impurity A; 7β-fulvestrant; 7beta-fulvestrant; Fulvestrant β-isomer. CAS No. 407577-53-1. Pack Sizes: 2.5 mg. Product ID: B1370-471901. Molecular formula: C32H47F5O3S. Mole weight: 606.79. Custom synthesis is available. Send your inquiries for more information. |  London |
| Fulvestrant EP Impurity D | Fulvestrant EP Impurity D is an impurity of Fulvestrant, which is an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Group: Pharmaceutical. Alternative Names: 7,7'-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17β-diol]; Fulvestrant Sterol Dimer (Mixture of Diastereomers). CAS No. 2483797-59-5. Pack Sizes: 10 mg. Product ID: B1370-455513. Molecular formula: C45H64O4. Mole weight: 668.99. Custom synthesis is available. Send your inquiries for more information. | London |
| Fulvestrant Extended | Fulvestrant Extended is an impurity of Fulvestrant, an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Group: Pharmaceutical. Alternative Names: (7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol. Pack Sizes: 10 mg. Product ID: B2694-471906. Molecular formula: C41H65F5O4S. Mole weight: 781.09. Custom synthesis is available. Send your inquiries for more information. | London |
| ?6-Fulvestrant | ?6-Fulvestrant is an impurity of Fulvestrant, which is a drug for breast cancer. Group: Pharmaceutical. Alternative Names: 7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10),6-tetraene-3,17β-diol; ?6,7-Fulvestrant; Fulvestrant EP Impurity E. CAS No. 2170200-14-1. Pack Sizes: 10 mg. Product ID: B2694-345580. Molecular formula: C32H45F5O3S. Mole weight: 604.75. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Keto Fulvestrant | 6-Keto Fulvestrant is an impurity of Fulvestrant, an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Group: Pharmaceutical. Alternative Names: 6-Keto-Fulvestrant; (7a,17ss)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-3,17ss-dihydroxyestra-1,3,5(10)-trien-6-one. Pack Sizes: 10 mg. Product ID: B2694-471908. Molecular formula: C32H45F5O4S. Mole weight: 620.77. Custom synthesis is available. Send your inquiries for more information. | London |
| S-Deoxo ?6-Fulvestrant | S-Deoxo ?6-Fulvestrant is an impurity of Fulvestrant, which is a drug for breast cancer. Group: Pharmaceutical. Alternative Names: 7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]estra-1,3,5(10),6-tetraene-3,17β-diol; S-Deoxo Fulvestrant Impurity E. CAS No. 2170200-16-3. Pack Sizes: 10 mg. Product ID: B2694-345581. Molecular formula: C32H45F5O2S. Mole weight: 588.75. Custom synthesis is available. Send your inquiries for more information. | London |
| S-Deoxo Fulvestrant | S-Deoxo Fulvestrant is a derivative of Fulvestrant, an estrogen receptor antagonist used as a medication indicated for the treatment of hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women. Group: Pharmaceutical. Alternative Names: (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol. CAS No. 153004-31-0. Pack Sizes: 1 g. Product ID: B2694-084722. Molecular formula: C32H47F5O2S. Mole weight: 590.77. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
